Risk and utility of platelet transfusion
Brubaker, L.H.; Rosenstein, D.L.
Missouri Medicine 72(5): 231
1975
ISSN/ISBN: 0026-6620 PMID: 1143257 Document Number: 83300
Document emailed within 1 workday
Related Documents
Vassallo, R.R. 2009: Recognition and management of antibodies to human platelet antigens in platelet transfusion-refractory patients Immunohematology 25(3): 119-124Amemiya, Y. 1997: Platelet transfusion refractoriness and effective management of platelet alloimmunization Nihon Rinsho. Japanese Journal of Clinical Medicine 55(9): 2392-2398
Holme, S.; Murphy, S. 1983: Platelet storage at 22 degrees C for transfusion: interrelationship of platelet density and size, medium pH, and viability after in vivo infusion Journal of Laboratory and Clinical Medicine 101(1): 161-174
Horejsí, J.; Novák, J.; Kselíková, M. 1979: Possibilities of the transfusion service in reducing the risk of hepatitis B transfer by blood transfusion preparations Czechoslovak Medicine 2(4): 179-185
Obayashi, T.; Taniguchi, H.; Mugitani, T.; Koh, T.; Kitagawa, K.; Kunishima, S.; Yamaguchi, A.; Yamagishi, H. 2001: Safety and utility of autologous blood transfusion for resection of metastatic liver tumor Hepato-Gastroenterology 48(39): 812-817
Castaigne, S. 1981: Platelet transfusion La Revue du Praticien 31(7): 519-522
Juji, T. 1978: Platelet and granulocyte transfusion and HLA Rinsho Byori. Japanese Journal of Clinical Pathology 26(10): 856-860
McFarland, J.G. 1996: Alloimmunization and platelet transfusion Seminars in Hematology 33(4): 315-328
Fohlen-Walter, A.; de Maistre, E.; Vigneron, C.; Lecompte, T.; Lesesve, J.F. 2003: Risk of underestimating platelet count because of the increase of mean platelet volume at the end of pregnancy Annales de Biologie Clinique 61(5): 589-592
Heldin, C.H.; Westermark, B. 1993: Possible in vivo effect and clinical utility of platelet-derived growth factor and PDGF antagonists Transplantation Proceedings 25(2): 2074-2076
Zwerling, C.; Ryan, J.; Schootman, M. 1993: A case-control study of risk factors for industrial low back injury. The utility of preplacement screening in defining high-risk groups Spine 18(9): 1242-1247
Murphy, W.G. 1992: Prophylactic platelet transfusion in acute leukaemia Lancet 339(8785): 120; Author Reply 120-1
Rock, G.; Labow, R.S.; Adams, G.A. 1988: Storage of human platelet concentrates for transfusion Progress in Clinical and Biological Research 283: 673-704
Finazzi, G. 1998: Prophylactic platelet transfusion in acute leukemia: which threshold should be used Haematologica 83(11): 961-962
Duquesnoy, R.J.; Vieira, J.; Aster, R.H. 1977: Donor availability for platelet transfusion support of alloimmunized thrombocytopenic patients Transplantation Proceedings 9(1): 519-521
Cid, J.; Lozano, M.; Nomdedeu, B.; Mazzara, R.; Vila, J.; Rives, S.; Ordinas, A. 1997: Staphylococcal sepsis associated with platelet transfusion: report of a new case and review of the literature Sangre 42(5): 407-409
Taaning, E.; Jacobsen, N. 1994: Platelet transfusion refractoriness due to graft-derived anti-HPA-2b production after allogeneic bone-marrow transplantation Transplantation Proceedings 26(3): 1826
Wongwiangjunt, S.; Poungvarin, N. 2012: Extensive bilateral ischemic stroke after platelet transfusion in thrombotic thrombocytopenic purpura (TTP): a case report Journal of the Medical Association of Thailand 95 Suppl. 2: S256-S260
Liu, G.-q.; Ding, H.-f.; Lu, X.-j.; Xu, M.; Xing, J.; Zhao, X.; Han, F.; Shang, Y.-h. 2012: The efficacy and safety of autologous cryopreserved platelet transfusion in management of thrombocytopenia after chemotherapy in hematological malignancy Zhonghua Nei Ke Za Zhi 51(3): 188-191
Ong, M.; Veillon, D.; Cotelingam, J. 2012: Is platelet transfusion necessary prior to a central venous catheter placement in thrombotic thrombocytopenic purpura patients? Journal of the Louisiana State Medical Society: Official Organ of the Louisiana State Medical Society 164(5): 283-284